article thumbnail

Apollo Aims to Grow Global Wealth Assets to $150B by 2029

Wealth Management

By 2029, the firm anticipates that the global wealth business could represent 50% of its annual third-party capital-raising volume.

Assets 114
article thumbnail

10 Monday AM Reads

The Big Picture

If all goes to plan, the spacecraft will arrive at 16 Psyche in August 2029. Business Owners Pay Premium to Hire Migrant Workers in Extremely Tight Labor Market : Employers, struggling to fill hourly wage jobs in construction, restaurants and other services, are offering higher pay and better working conditions to people coming to the U.S.

Economy 284
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

If It Sounds Too Good To Be True…

The Big Picture

2029 Century Park E. That MSRP can be considered a bargain reveals how much prices have risen, and just how much status is in these watches. For consumers and investors alike, TANSTAAFL is the rule: Anything that looks too good to be true probably is. Contact Information: Mz Global Holdings, Inc. Los Angeles, CA 90067.

Retail 332
article thumbnail

Apollo Assets Reach $733 Billion, Boosted by Wealth Clients

Wealth Management

Apollo, like its peers, continues to target high earners for higher-fee-paying assets and has set a goal of raising at least $150 billion for its global wealth business by 2029.

Assets 110
article thumbnail

Apollo Assets Reach $733 Billion, Boosted by Wealth Clients

Wealth Management

Apollo, like its peers, continues to target high earners for higher-fee-paying assets and has set a goal of raising at least $150 billion for its global wealth business by 2029.

Assets 102
article thumbnail

Apollo Assets Reach $733 Billion, Boosted by Wealth Clients

Wealth Management

Apollo, like its peers, continues to target high earners for higher-fee-paying assets and has set a goal of raising at least $150 billion for its global wealth business by 2029.

Assets 98
article thumbnail

: Bausch Health stock soars after company says rival application for generic version of its IBS drug can’t be approved until 2029

MarketWatch

district court stuck with an earlier judgment that prevented an application for a rival generic version of its Xifaxan irritable bowel syndrome drug from getting FDA approval until 2029, sending shares higher during regular and after-hours trade. BHC on Wednesday said a U.S.